thiazoles has been researched along with glucagon-like peptide 1 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demuth, HU; Lynn, F; McIntosh, CH; Pauly, RP; Pederson, RA; Rosche, F; Schmidt, J; White, HA | 1 |
| Gallwitz, B; Schmidt, WE | 1 |
| Feinglos, MN; Hughes, AT; Luna, B | 1 |
| Caro, J; Wishner, KL | 1 |
| Moller, DE; Zhang, BB | 1 |
| Dharmalingam, M; Kumar, P | 1 |
| Chen, D; Egan, JM; Greig, NH; Lahiri, DK; Perry, T; Shaw, KT; Zhou, J | 1 |
| Bloomgarden, ZT | 1 |
| Smith, SA; Tadayyon, M | 1 |
| Berg, S; Freyse, EJ; Heinke, P; Kohnert, KD; Salzsieder, E | 1 |
| Hu, B; Huang, Y; Mao, L; Mei, YW; Wang, MD; Xia, YP; Zhang, GP | 1 |
| Christiansen, E; Due-Hansen, ME; Hansen, AM; Hudson, BD; Mackenzie, AE; Marquez, R; Milligan, G; Murdoch, H; Pandey, SK; Tikhonova, IG; Ulven, T; Ward, RJ | 1 |
| Bahirat, UA; Goel, RN; Nemmani, KV; Shenoy, RR | 1 |
| Chiba, K; Ishimoto, Y; Matsumoto, K; Takahashi, K; Tanaka, N; Watanabe, A; Yoshitomi, T | 1 |
5 review(s) available for thiazoles and glucagon-like peptide 1
| Article | Year |
|---|---|
The use of insulin secretagogues in the treatment of type 2 diabetes.
Topics: Acarbose; Carbamates; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Metformin; Peptide Fragments; Piperidines; Protein Precursors; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Research advances in the treatment of type 2 diabetes mellitus.
Topics: Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Peptide Fragments; Protein Kinase C; Protein Precursors; Research; Thiazoles; Thiazolidinediones | 1999 |
New approaches in the treatment of type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Liver; Molecular Structure; Peptide Fragments; Protein Precursors; Protein Tyrosine Phosphatases; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Receptors, Glucagon; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
Topics: Amyloid; Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Peptide Fragments; Protein Precursors; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Insulin sensitisation in the treatment of Type 2 diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenergic beta-3 Receptor Agonists; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hydroxysteroid Dehydrogenases; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Metformin; Peptide Fragments; Protein Precursors; Randomized Controlled Trials as Topic; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Transcription Factors | 2003 |
9 other study(ies) available for thiazoles and glucagon-like peptide 1
| Article | Year |
|---|---|
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide.
Topics: Animals; Colorimetry; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Insulin; Isoleucine; Male; Peptide Fragments; Protein Precursors; Radioimmunoassay; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Thiazoles | 1999 |
[Inhibition of incretin degradation--a new therapy principle for treatment of type 2 diabetes?].
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Isoleucine; Peptide Fragments; Rats; Rats, Zucker; Thiazoles | 1999 |
A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
Topics: Amino Acid Sequence; Animals; Antimetabolites; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Differentiation; Cyclic AMP; DNA Replication; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Immunohistochemistry; L-Lactate Dehydrogenase; Molecular Sequence Data; Nerve Growth Factor; Neurodegenerative Diseases; PC12 Cells; Peptide Fragments; Peptides; Protein Precursors; Rats; Receptors, Glucagon; Stimulation, Chemical; Tetrazolium Salts; Thiazoles; Venoms | 2002 |
Pharmacologic treatment of type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Exenatide; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Monosaccharide Transport Proteins; Obesity; Peptide Fragments; Peptide Hormones; Peptides; Peroxisome Proliferators; Protein Precursors; Receptors, Cell Surface; Thiazoles; Venoms | 2003 |
DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Glucose; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Incretins; Insulin; Isoleucine; Male; Rats; Rats, Wistar; Thiazoles | 2011 |
Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway.
Topics: Animals; Animals, Newborn; Apoptosis; Blotting, Western; Brain Ischemia; Cell Survival; Cerebral Cortex; Coloring Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Endoplasmic Reticulum; Exenatide; Flow Cytometry; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose; Hypoxia; Neurons; Neuroprotective Agents; PC12 Cells; Peptides; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; Tetrazolium Salts; Thiazoles; Venoms | 2012 |
Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor.
Topics: Adipocytes; Allosteric Regulation; Amino Acid Motifs; Amino Acid Substitution; Animals; Benzeneacetamides; Binding Sites; Butyrates; Cyclopropanes; Enteroendocrine Cells; Glucagon-Like Peptide 1; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Lipolysis; Mice; Models, Molecular; Mutagenesis, Site-Directed; Protein Binding; Protein Structure, Tertiary; Rats; Receptors, Cell Surface; Thiazoles | 2013 |
APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice.
Topics: Animals; Diet, High-Fat; Drug Interactions; Gastric Emptying; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Linagliptin; Male; Mesylates; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxadiazoles; Polyethylene Glycols; Pyrazoles; Pyrimidines; Receptors, G-Protein-Coupled; Tetrazoles; Thiazoles; Triglycerides | 2017 |
DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
Topics: Animals; Benzamides; CHO Cells; Cricetulus; Cyclopropanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mesylates; Mice; Oxadiazoles; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, G-Protein-Coupled; Tetrazoles; Thiazoles; Up-Regulation | 2018 |